valine has been researched along with Cytomegalovirus Infections in 105 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 20 (19.05) | 18.2507 |
| 2000's | 51 (48.57) | 29.6817 |
| 2010's | 34 (32.38) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jones, C; Khalil, A; Ville, Y | 1 |
| Bion, JF; Cowley, NJ; Ives, N; Millar, J; Moss, P; Osman, H; Owen, A; Shiels, SC; Woolley, R | 1 |
| Craig, JC; Hodson, EM; Ladhani, M; Strippoli, GF; Webster, AC | 1 |
| Benoist, G; Jacquemard, F; Leruez-Ville, M; Magny, JF; Salomon, LJ; Ville, Y | 1 |
| Beersma, MF; Bouts, AH; Cornelissen, EA; Cransberg, K; Jongsma, H | 1 |
| Dong, LQ; Guan, LB; Li, SF; Wang, W; Yu, P; Zhang, L; Zhang, P; Zhou, S | 1 |
| Asbjörnsdóttir, K; Atkinson, C; Boeckh, M; Drake, AL; Emery, V; Farquhar, C; John-Stewart, G; Kiarie, JN; Richardson, B; Roxby, AC; Slyker, JA; Wald, A | 1 |
| Hirano, T; Tsuda, H; Tsuji, T; Yamasaki, H | 1 |
| Alvarez-Cañas, MC; Linares-Torres, P; Pisabarros-Blanco, C; Sierra-Ausin, M | 1 |
| Kacer, M; Reischig, T | 1 |
| Bouda, M; Hes, O; Jindra, P; Kacer, M; Lysak, D; Reischig, T | 1 |
| Goggins, M; Kahlon, P; Nabi, S; Patel, A | 1 |
| Bouda, M; Kacer, M; Kielberger, L; Reischig, T | 1 |
| Kavasoglu, K; Kervan, U; Kocabeyoglu, SS; Kucuker, SA; Ozatik, MA; Pac, M; Sert, DE; Tezer, AY; Unal, EU | 1 |
| Aegerter, P; Benoist, G; Bussières, L; Couderc, S; Ghout, I; Guilleminot, T; Jacquemard, F; Leruez-Ville, M; Magny, JF; Picone, O; Salomon, LJ; Stirnemann, J; Ville, Y; Winer, N | 1 |
| Chanouzas, D; Dyall, L; Ferro, C; Harper, L; Morgan, MD; Moss, P; Nightingale, P | 1 |
| De Santis, M; Straface, G; Zanardo, V | 1 |
| Leruez-Ville, M; Ville, Y | 1 |
| Smolej, L | 1 |
| Boronow, JJ; Dickerson, FB; Origoni, AE; Stallings, CR; Sullens, A; Yolken, RH | 1 |
| Bouda, M; Hes, O; Jindra, P; Nemcová, J; Reischig, T; Treska, V; Vanecek, T | 1 |
| Akl, A; Blancho, G; Cantarovich, D; Dantal, J; Giral, M; Leone, F; Soulillou, JP | 1 |
| Aydinli, B; Bilen, Y; Cetinkaya, R; Keles, M; Polat, KY; Turkmen, M; Uyanik, A; Yildirim, R | 1 |
| Chiang, CC; Lin, TH; Tien, PT; Tsai, YY | 1 |
| Cohney, SJ; Nicholls, K; Tan, MB; Toussaint, ND; Walker, RG | 1 |
| Reischig, T | 1 |
| Bouda, M; Jindra, P; Lysak, D; Matejovic, M; Prucha, M; Reischig, T; Sedlackova, L | 1 |
| Abdulbaki, A; Aoun, EG; Baidoo, L; Hashash, JG; Refaat, M | 1 |
| Bouda, M; Jindra, P; Kielberger, L; Reischig, T | 1 |
| Abd-Alla, AM; Adun, H; Bergoin, M; Parker, AG; Vreysen, MJ | 1 |
| Brennan, DC; Santos, RD | 1 |
| Bouda, M; Hes, O; Hribova, P; Jindra, P; Reischig, T; Treska, V; Viklicky, O | 1 |
| Chang, CY; Chiu, HY; Hsiao, CH; Wang, LF | 1 |
| Alexopoulos, SP; Lindberg, L; Matsuoka, L; Subramanyan, RK | 1 |
| Beswick, M; Lauder, SN; Moss, PA; Pachnio, A; Sweet, C | 1 |
| Döhler, B; Eriksson, BM; Opelz, G; Sund, F; Tufveson, G | 1 |
| Brown, TJ; McCrary, M; Tyring, SK | 1 |
| Ljungman, P | 1 |
| Legendre, C; Squifflet, JP | 1 |
| Fiddian, P; Griffiths, PD; Sabin, CA | 1 |
| Zaia, JA | 1 |
| Anglicheau, D; Flamant, M; Lautrette, A; Legendre, C; Martinez, F; Morinet, F; Scieux, C; Thervet, E | 1 |
| Emery, VC; Leśnikowski, ZJ; Olejniczak, A; Paradowska, E; Przepiórkiewicz, M | 1 |
| Bouda, M; Jindra, P; Opatrny, K; Reischig, T; Svecova, M; Treska, V | 1 |
| Baud, J; El Haggan, W; Hurault de Ligny, B; Naguib, D; Troussard, X | 1 |
| Chandrasekar, PH; Petersen, FB; Snydman, DR; Territo, MC; Winston, DJ; Yeager, AM | 1 |
| Beaulieu, J; Dworkin, L; Gohh, R; Monaco, A; Morrissey, P; Shemin, D; Yango, A; Zanabli, A | 1 |
| Bérard, M; Davani, S; Kantelip, JP; Rifle, G; Royer, B; Tanter, Y; Zanetta, G | 1 |
| Darby, CR; Devaney, A; Friend, PJ; Handa, A; Hughes, D; Mason, P; Reddy, SP; Tan, L | 1 |
| Anglicheau, D; Flamant, M; Lautrette, A; Legendre, C; Morinet, F; Scieux, C | 1 |
| Feinberg, J; Jacobson, DL; Wu, AW | 1 |
| Boronow, JJ; Dickerson, FB; Origoni, AE; Stallings, CR; Yolken, RH | 1 |
| Chapman, J; Crowley, S; Davey, PJ; Solly, ML; Tilden, DP | 1 |
| Alain, S; Champier, G; Cogne, N; De Wilde, A; Denis, F; Fillet, AM; Gouarin, S; Hantz, S; Imbert, BM; Karras, A; Legendre, C; Mazeron, MC; Mengelle, C; Rogez, S; Scieux, C; Szelag, JC | 1 |
| Ioannidis, J; Wilkinson, D | 2 |
| Cechura, M; Hes, O; Jindra, P; Mares, J; Opatrný, K; Reischig, T; Svecová, M; Treska, V | 1 |
| Beard, SM; Crochard, A; Durand-Zaleski, I; Lebranchu, Y; Legendre, C; Pouteil-Noble, C; Richter, A | 1 |
| Alain, S; Bensman, A; Champier, G; Dehee, A; Denis, F; Fillet, AM; Guigonis, V; Hantz, S; Mazeron, MC; Mertens, T; Michel, D | 1 |
| Jindra, P; Mares, J; Opatrný, K; Reischig, T; Svecová, M; Treska, V | 1 |
| Boletis, JN; Chelioti, H; Daikos, GL; Kostakis, A; Pavlopoulou, ID; Stamatiades, D; Syriopoulou, VP | 1 |
| Barclay, PG; Craig, JC; Hodson, EM; Jones, C; Kable, K; Strippoli, GF; Vimalachandra, D; Webster, AC | 1 |
| Chen, L; Ng, AP; Prince, HM; Seymour, JF; Slavin, M; Thursky, K; Worth, L | 1 |
| Artz, A; Godley, L; Kline, J; Larson, RA; Pollyea, DA; Pursell, K; Rich, E; Stock, W; Thompson, K; van Besien, K; Zimmerman, T | 1 |
| Das, V; Legendre, C; Peraldi, MN | 1 |
| Goh, CL; Tan, HH | 1 |
| Jindra, P; Kormunda, S; Opatrný, K; Reischig, T; Svecová, M; Treska, V | 1 |
| Aisa, Y; Ikeda, Y; Mori, T; Nakazato, T; Okamoto, S; Shimizu, T; Yamazaki, R | 1 |
| Falagas, ME; Vardakas, KZ | 1 |
| Costa, JM; Daffos, F; Dejean, A; Jacquemard, F; Jaqz-Aigrain, E; Romand, S; Ville, Y; Yamamoto, M | 1 |
| Chihara, H; Hara, Y; Inatomi, T; Kawasaki, S; Kinoshita, S; Koizumi, N; Mochida, C; Ohashi, Y; Shiraishi, A; Sotozono, C; Suzuki, T; Uno, T; Yamasaki, K | 1 |
| Hes, O; Jindra, P; Klaboch, J; Reischig, T; Svecová, M; Treska, V | 1 |
| Craig, JC; Hodson, EM; Strippoli, GF; Webster, AC | 1 |
| Darby, G | 1 |
| Bowen, EF; Davey, CC; Emery, VC; Griffiths, PD; Johnson, MA | 1 |
| Itin, PH; Lautenschlager, S | 1 |
| Bell, WR; Chulay, JD; Feinberg, JE | 1 |
| Coakley, D; Cooper, D; Feinberg, JE; Fry, J; Gill, MJ; Griffiths, PD; Holland, FJ; Holland, GN; Hurwitz, S; Jacobson, MA; MacGregor, RR; Owens, S; Pollard, RB; Powderly, W; Power, ME; Sattler, FR; Youle, M | 1 |
| Ansari, A; Dix, L; Emery, VC; Feinberg, JE; Fry, J; Gor, D; Griffiths, PD; Sabin, C | 1 |
| Bujko, M; Cvetković, M; Jovanović, T; Kokai, D; Ljubić, A; Novakov, A; Sulović, V; Vukolić, D | 1 |
| Binswanger, U; Himmelmann-Jud, B; Weinreich, T; Wüthrich, RP | 1 |
| Brennan, PJ; Coggon, GL; Crisp, A; Keating, MR; Kovarik, J; Lee, IC; Legendre, CM; Lowance, D; Mendez, R; Neumayer, HH; Norman, D; Squifflet, JP | 1 |
| Emery, VC; Feinberg, JE; Griffiths, PD; Grywacz, M; Knight, S; Sabin, C | 1 |
| Kuypers, DR; Vanrenterghem, YF | 1 |
| Bell, AR | 1 |
| Le Meur, Y; Leroux-Robert, C; Moesch, C; Mons, S | 1 |
| Ormrod, D; Perry, CM; Scott, LJ | 1 |
| Legendre, C | 1 |
| Grant, DM; Keating, MR; Legendre, CM; Maclaine, GD; Norman, DJ | 1 |
| Annemans, L; Maclaine, G; Mauskopf, JA; Richter, A | 1 |
| James, JS | 1 |
| Cheng, B | 1 |
| Glick, ME | 1 |
| Torres, G | 1 |
| Spector, SA | 1 |
| Feinberg, J | 1 |
| Brandt, SJ; Dummer, JS; Goodman, SA; Greer, JP; Morgan, DS; Schuening, FG; Stein, RS; Vusirikala, M; Wolff, SN | 1 |
| Eriksson, BM; Sund, F; Wahlberg, J | 1 |
| Chang, R; MacPhee, I; Ostermann, M | 1 |
| Carroll, KB; Crisp, A; Egan, JJ; Woodcock, A; Yonan, N | 1 |
| Crisp, A; de La Camara, R; Ljungman, P; Milpied, N; Russell, CA; Volin, L; Webster, A | 1 |
| De Gruttola, V; Emery, VC; Feinberg, JE; Griffiths, P; Holland, F; Jacobson, MA; Nokta, MA; Pollard, RB | 1 |
22 review(s) available for valine and Cytomegalovirus Infections
| Article | Year |
|---|---|
Congenital cytomegalovirus infection: management update.
Topics: Acyclovir; Antiviral Agents; Clinical Trials, Phase II as Topic; Cytomegalovirus; Cytomegalovirus Infections; Double-Blind Method; Female; Fetal Diseases; Humans; Immunoglobulins; Infant, Newborn; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Randomized Controlled Trials as Topic; Valacyclovir; Valine | 2017 |
Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients.
Topics: Acyclovir; Antiviral Agents; Cytomegalovirus Infections; Ganciclovir; Humans; Organ Transplantation; Randomized Controlled Trials as Topic; Valacyclovir; Valine | 2013 |
Management of pregnancies with confirmed cytomegalovirus fetal infection.
Topics: Acyclovir; Amniocentesis; Amniotic Fluid; Antiviral Agents; Congenital Abnormalities; Cytomegalovirus; Cytomegalovirus Infections; Decision Trees; Female; Fetal Diseases; Humans; Infant, Newborn; Male; Pregnancy; Prognosis; Severity of Illness Index; Ultrasonography; Valacyclovir; Valine | 2013 |
The efficacy and cost-effectiveness of valacyclovir in cytomegalovirus prevention in solid organ transplantation.
Topics: Acyclovir; Antiviral Agents; Cost Savings; Cost-Benefit Analysis; Cytomegalovirus Infections; Drug Costs; Humans; Organ Transplantation; Treatment Outcome; Valacyclovir; Valine | 2014 |
Fetal cytomegalovirus infection.
Topics: Acyclovir; Amniotic Fluid; Antibodies, Viral; Antiviral Agents; Ascites; Cytomegalovirus Infections; DNA, Viral; Female; Fetal Diseases; Humans; Hydrocephalus; Hydrops Fetalis; Immunization, Passive; Immunoglobulin G; Immunoglobulin M; Infectious Disease Transmission, Vertical; Lissencephaly; Microcephaly; Oligohydramnios; Polyhydramnios; Porencephaly; Pregnancy; Pregnancy Complications, Infectious; Seroconversion; Ultrasonography, Prenatal; Valacyclovir; Valine | 2017 |
Advances in cytomegalovirus-preventive strategies in solid organ transplantation: defending pre-emptive therapy.
Topics: Acyclovir; Antiviral Agents; Clinical Protocols; Cytomegalovirus Infections; Ganciclovir; Humans; Immunosuppressive Agents; Opportunistic Infections; Organ Transplantation; Randomized Controlled Trials as Topic; Valacyclovir; Valganciclovir; Valine | 2012 |
Antiviral agents: Non-antiretroviral [correction of Nonantiviral] drugs.
Topics: 2-Aminopurine; Acyclovir; Antiviral Agents; Chickenpox; Cytomegalovirus Infections; Famciclovir; Foscarnet; Guanine; Hepatitis B; Hepatitis C; Herpes Genitalis; Herpes Simplex; Herpesvirus 3, Human; Herpesvirus 8, Human; Humans; Papillomavirus Infections; Sarcoma, Kaposi; Skin Diseases, Viral; Valacyclovir; Valine | 2002 |
Beta-herpesvirus challenges in the transplant recipient.
Topics: Acyclovir; Antiviral Agents; Betaherpesvirinae; Clinical Trials as Topic; Cytomegalovirus Infections; Hematopoietic Stem Cell Transplantation; Herpesviridae Infections; Herpesvirus 6, Human; Herpesvirus 7, Human; Humans; Organ Transplantation; Postoperative Complications; Treatment Outcome; Valacyclovir; Valine | 2002 |
The economic value of valacyclovir prophylaxis in transplantation.
Topics: Acyclovir; Administration, Oral; Antiviral Agents; Bone Marrow Transplantation; Cost-Benefit Analysis; Cytomegalovirus Infections; Graft Rejection; Health Care Costs; Heart Transplantation; Humans; Kidney Transplantation; Opportunistic Infections; Postoperative Complications; Prodrugs; Time Factors; Valacyclovir; Valine | 2002 |
Valacyclovir provides optimum acyclovir exposure for prevention of cytomegalovirus and related outcomes after organ transplantation.
Topics: Acyclovir; Antiviral Agents; Cytomegalovirus Infections; Dose-Response Relationship, Drug; Graft Rejection; Herpes Simplex; Humans; Odds Ratio; Opportunistic Infections; Organ Transplantation; Postoperative Complications; Prodrugs; Randomized Controlled Trials as Topic; Treatment Outcome; Valacyclovir; Valine | 2002 |
[Drugs against human cytomegalovirus].
Topics: Acyclovir; AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cytomegalovirus Infections; Cytosine; Drugs, Investigational; Female; Foscarnet; Ganciclovir; Global Health; Humans; Infectious Disease Transmission, Vertical; Naphthalenesulfonates; Organophosphonates; Organophosphorus Compounds; Pregnancy; Pregnancy Complications, Infectious; Thionucleotides; Valacyclovir; Valganciclovir; Valine | 2002 |
HIV: opportunistic infections.
Topics: Acyclovir; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Anti-Infective Agents; Antitubercular Agents; Antiviral Agents; Atovaquone; Azithromycin; Chickenpox; Clarithromycin; Cytomegalovirus Infections; Drug Therapy, Combination; Ganciclovir; Herpes Simplex; Humans; Mycobacterium avium-intracellulare Infection; Naphthoquinones; Pneumonia, Pneumocystis; Rifabutin; Toxoplasmosis; Trimethoprim, Sulfamethoxazole Drug Combination; Tuberculosis, Pulmonary; Valacyclovir; Valine | 2003 |
HIV: prevention of opportunistic infections.
Topics: 2-Aminopurine; Acyclovir; AIDS-Related Opportunistic Infections; Anti-Infective Agents; Antifungal Agents; Antiprotozoal Agents; Antiretroviral Therapy, Highly Active; Antitubercular Agents; Antiviral Agents; Atovaquone; Azithromycin; Clarithromycin; Cytomegalovirus Infections; Drug Therapy, Combination; Famciclovir; Herpes Simplex; Herpes Zoster; Humans; Mycobacterium avium-intracellulare Infection; Mycoses; Naphthoquinones; Pneumonia, Pneumocystis; Toxoplasmosis; Trimethoprim, Sulfamethoxazole Drug Combination; Tuberculosis, Pulmonary; Valacyclovir; Valine | 2003 |
Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients.
Topics: Acyclovir; Antiviral Agents; Cytomegalovirus Infections; Ganciclovir; Humans; Organ Transplantation; Valacyclovir; Valine | 2005 |
Viral infections affecting the skin in organ transplant recipients: epidemiology and current management strategies.
Topics: 2-Aminopurine; Acyclovir; Antiviral Agents; Cidofovir; Cytomegalovirus Infections; Cytosine; Drug Administration Schedule; Epstein-Barr Virus Infections; Famciclovir; Foscarnet; Herpes Zoster; Herpesviridae Infections; Humans; Immunocompromised Host; Molluscum Contagiosum; Organ Transplantation; Organophosphonates; Papillomavirus Infections; Skin Diseases, Viral; Trifluridine; Valacyclovir; Valine | 2006 |
Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients.
Topics: Acyclovir; Antiviral Agents; Cytomegalovirus Infections; Ganciclovir; Humans; Organ Transplantation; Valine | 2008 |
Acyclovir--and beyond.
Topics: Acyclovir; Arabinofuranosyluracil; Cytomegalovirus Infections; Ganciclovir; Guanine; Herpes Simplex; Herpesvirus 3, Human; Humans; Valacyclovir; Valine | 1994 |
Lessons from the natural history of cytomegalovirus.
Topics: Acyclovir; Administration, Oral; AIDS-Related Opportunistic Infections; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; Cytomegalovirus Retinitis; Ganciclovir; Humans; Polymerase Chain Reaction; Risk Factors; Valacyclovir; Valine | 1996 |
Viral lesions of the mouth in HIV-infected patients.
Topics: 2-Aminopurine; Acyclovir; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Cytomegalovirus Infections; Disease Progression; Famciclovir; Foscarnet; Ganciclovir; Herpesviridae Infections; Herpesvirus 1, Human; Herpesvirus 2, Human; Herpesvirus 4, Human; Herpesvirus 8, Human; Humans; Leukoplakia, Hairy; Lymphoma, B-Cell; Lymphoma, T-Cell; Molluscum Contagiosum; Mouth Diseases; Mouth Neoplasms; Oral Ulcer; Prodrugs; Sarcoma, Kaposi; Stomatitis, Herpetic; Tumor Virus Infections; Valacyclovir; Valine; Virus Diseases; Warts | 1997 |
Prophylaxis of cytomegalovirus infection in renal transplantation: new data for an old problem.
Topics: Acyclovir; Antiviral Agents; Clinical Trials as Topic; Cytomegalovirus Infections; Ganciclovir; Humans; Kidney Transplantation; Postoperative Complications; Valacyclovir; Valine | 1999 |
Valaciclovir update.
Topics: Acyclovir; Antiviral Agents; Cytomegalovirus Infections; Herpes Genitalis; Herpes Zoster; Humans; Prodrugs; Valacyclovir; Valine | 1999 |
Valaciclovir: a review of its long term utility in the management of genital herpes simplex virus and cytomegalovirus infections.
Topics: Acyclovir; Animals; Antiviral Agents; Cytomegalovirus Infections; Herpes Genitalis; Humans; Valacyclovir; Valine | 2000 |
32 trial(s) available for valine and Cytomegalovirus Infections
| Article | Year |
|---|---|
Safety and Efficacy of Antiviral Therapy for Prevention of Cytomegalovirus Reactivation in Immunocompetent Critically Ill Patients: A Randomized Clinical Trial.
Topics: Acyclovir; Adult; Aged; Antiviral Agents; Critical Illness; Cytomegalovirus; Cytomegalovirus Infections; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Opportunistic Infections; Respiration, Artificial; Valacyclovir; Valine; Virus Activation; Virus Inactivation | 2017 |
Maternal valacyclovir and infant cytomegalovirus acquisition: a randomized controlled trial among HIV-infected women.
Topics: Acyclovir; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; Female; HIV Seropositivity; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Milk, Human; Pregnancy; Premedication; Treatment Outcome; Valacyclovir; Valine; Viral Load; Virus Shedding | 2014 |
Randomized trial of valganciclovir versus valacyclovir prophylaxis for prevention of cytomegalovirus in renal transplantation.
Topics: Acute Disease; Acyclovir; Adult; Antiviral Agents; Biomarkers; Biopsy; Cytomegalovirus; Cytomegalovirus Infections; Czech Republic; DNA, Viral; Drug Administration Schedule; Female; Ganciclovir; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Intention to Treat Analysis; Kidney Transplantation; Male; Middle Aged; Time Factors; Treatment Outcome; Valacyclovir; Valganciclovir; Valine; Viral Load | 2015 |
In utero treatment of congenital cytomegalovirus infection with valacyclovir in a multicenter, open-label, phase II study.
Topics: Acyclovir; Adult; Antiviral Agents; Cytomegalovirus Infections; Female; Fetal Blood; Fetal Diseases; Fetal Therapies; Humans; Infant, Newborn; Platelet Count; Pregnancy; Pregnancy Complications, Infectious; Pregnancy, High-Risk; Ultrasonography, Prenatal; Valacyclovir; Valine; Viral Load | 2016 |
Valaciclovir to prevent Cytomegalovirus mediated adverse modulation of the immune system in ANCA-associated vasculitis (CANVAS): study protocol for a randomised controlled trial.
Topics: Acyclovir; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Antiviral Agents; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; Clinical Protocols; Cytomegalovirus; Cytomegalovirus Infections; England; Host-Pathogen Interactions; Humans; Proof of Concept Study; Prospective Studies; Research Design; Time Factors; Treatment Outcome; Valacyclovir; Valine; Viral Load; Virus Activation | 2016 |
Double blind trial of adjunctive valacyclovir in individuals with schizophrenia who are seropositive for cytomegalovirus.
Topics: Acyclovir; Adult; Antipsychotic Agents; Antiviral Agents; Baltimore; Comorbidity; Cytomegalovirus Infections; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Psychotic Disorders; Schizophrenia; Schizophrenic Psychology; Valacyclovir; Valine | 2009 |
Intragraft cytomegalovirus infection: a randomized trial of valacyclovir prophylaxis versus pre-emptive therapy in renal transplant recipients.
Topics: Acyclovir; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; Double-Blind Method; Ganciclovir; Graft Rejection; Humans; Kidney Transplantation; Postoperative Complications; Premedication; Risk Factors; Transplantation, Homologous; Treatment Outcome; Valacyclovir; Valganciclovir; Valine; Viremia | 2010 |
Pharmacoeconomic impact of different regimens to prevent cytomegalovirus infection in renal transplant recipients.
Topics: Acyclovir; Adult; Antiviral Agents; Cytomegalovirus Infections; Economics, Pharmaceutical; Female; Ganciclovir; Graft Survival; Humans; Kidney Transplantation; Male; Middle Aged; Postoperative Complications; Prospective Studies; Valacyclovir; Valine | 2012 |
Long-term outcomes of pre-emptive valganciclovir compared with valacyclovir prophylaxis for prevention of cytomegalovirus in renal transplantation.
Topics: Acyclovir; Adult; Antiviral Agents; Atrophy; Biopsy; Cytomegalovirus; Cytomegalovirus Infections; Female; Fibrosis; Follow-Up Studies; Ganciclovir; Graft Survival; Humans; Kaplan-Meier Estimate; Kidney; Kidney Transplantation; Longitudinal Studies; Male; Middle Aged; Treatment Outcome; Valacyclovir; Valganciclovir; Valine | 2012 |
A randomized prospective controlled trial of oral ganciclovir versus oral valacyclovir for prophylaxis of cytomegalovirus disease after renal transplantation.
Topics: Acyclovir; Administration, Oral; Adult; Antiviral Agents; Cadaver; Cytomegalovirus Infections; Dose-Response Relationship, Drug; Female; Ganciclovir; Humans; Kidney Diseases; Kidney Transplantation; Living Donors; Male; Middle Aged; Postoperative Complications; Prospective Studies; Renal Insufficiency; Tissue Donors; Valacyclovir; Valine | 2002 |
Randomized comparison of oral valacyclovir and intravenous ganciclovir for prevention of cytomegalovirus disease after allogeneic bone marrow transplantation.
Topics: Acyclovir; Administration, Oral; Adolescent; Adult; Aged; Antiviral Agents; Bacterial Infections; Bone Marrow Transplantation; Cytomegalovirus; Cytomegalovirus Infections; Female; Ganciclovir; Humans; Injections, Intravenous; Male; Microbial Sensitivity Tests; Middle Aged; Mycoses; Sepsis; Survival Analysis; Transplantation, Homologous; Valacyclovir; Valine | 2003 |
Health-related quality of life predicts survival, cytomegalovirus disease, and study retention in clinical trial participants with advanced HIV disease.
Topics: Acute Disease; Acyclovir; Adult; Age Factors; Anti-HIV Agents; Cytomegalovirus Infections; Double-Blind Method; Health Status; HIV Infections; Humans; Middle Aged; Patient Dropouts; Predictive Value of Tests; Proportional Hazards Models; Psychiatric Status Rating Scales; Quality of Life; Racial Groups; Sex Factors; Survival Rate; Valacyclovir; Valine | 2003 |
Reduction of symptoms by valacyclovir in cytomegalovirus-seropositive individuals with schizophrenia.
Topics: Acyclovir; Adult; Antiviral Agents; Cytomegalovirus Infections; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Middle Aged; Prodrugs; Psychiatric Status Rating Scales; Psychotic Disorders; Schizophrenia; Schizophrenic Psychology; Treatment Outcome; Valacyclovir; Valine | 2003 |
Valacyclovir for cytomegalovirus prophylaxis reduces the risk of acute renal allograft rejection.
Topics: Acyclovir; Adult; Antiviral Agents; Cytomegalovirus Infections; Female; Ganciclovir; Graft Rejection; Histocompatibility Testing; Humans; Immunosuppressive Agents; Kidney Diseases; Kidney Transplantation; Male; Middle Aged; Reoperation; Risk Factors; Survival Analysis; Time Factors; Transplantation, Homologous; Valacyclovir; Valine | 2005 |
Prospective comparison of valacyclovir and oral ganciclovir for prevention of cytomegalovirus disease in high-risk renal transplant recipients.
Topics: Acyclovir; Administration, Oral; Adult; Antiviral Agents; Cytomegalovirus Infections; Female; Ganciclovir; Graft Rejection; Graft Survival; Health Care Costs; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Postoperative Complications; Prospective Studies; Risk Factors; Valacyclovir; Valine; Viremia | 2005 |
A comparative randomised study of valacyclovir vs. oral ganciclovir for cytomegalovirus prophylaxis in renal transplant recipients.
Topics: Acyclovir; Administration, Oral; Adult; Antiviral Agents; Costs and Cost Analysis; Cytomegalovirus Infections; Female; Ganciclovir; Greece; Humans; Kidney Transplantation; Male; Postoperative Complications; Valacyclovir; Valine | 2005 |
Pre-transplant ganciclovir and post transplant high-dose valacyclovir reduce CMV infections after alemtuzumab-based conditioning.
Topics: Acyclovir; Adolescent; Adult; Aged; Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Antineoplastic Agents; Antiviral Agents; Bone Marrow Transplantation; Cytomegalovirus Infections; Female; Ganciclovir; Hematologic Neoplasms; Humans; Incidence; Male; Middle Aged; Transplantation Conditioning; Transplantation, Homologous; Valacyclovir; Valine | 2006 |
The impact of cytomegalovirus disease and asymptomatic infection on acute renal allograft rejection.
Topics: Acute Disease; Acyclovir; Antiviral Agents; Carrier State; Cytomegalovirus; Cytomegalovirus Infections; Female; Ganciclovir; Graft Rejection; Humans; Incidence; Kidney Transplantation; Male; Middle Aged; Multivariate Analysis; Postoperative Complications; Prospective Studies; Risk Factors; Treatment Outcome; Valacyclovir; Valine | 2006 |
Prevention of cytomegalovirus infection by valaciclovir after allogeneic bone marrow transplantation from an unrelated donor.
Topics: Acyclovir; Adolescent; Adult; Antiviral Agents; Bone Marrow Transplantation; Cytomegalovirus Infections; DNA, Viral; Female; Humans; Lymphoproliferative Disorders; Male; Middle Aged; Prospective Studies; Transplantation, Homologous; Valacyclovir; Valine | 2006 |
Valacyclovir prophylaxis versus preemptive valganciclovir therapy to prevent cytomegalovirus disease after renal transplantation.
Topics: Acyclovir; Adult; Aged; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; Czech Republic; Ganciclovir; Humans; Incidence; Kidney Transplantation; Middle Aged; Prospective Studies; Valacyclovir; Valganciclovir; Valine | 2008 |
Manifestations resembling thrombotic microangiopathy in patients with advanced human immunodeficiency virus (HIV) disease in a cytomegalovirus prophylaxis trial (ACTG 204).
Topics: Acyclovir; Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Cytomegalovirus Infections; Double-Blind Method; Hemolytic-Uremic Syndrome; HIV Infections; Humans; Male; Middle Aged; Prodrugs; Prospective Studies; Purpura, Thrombotic Thrombocytopenic; Risk Factors; Valacyclovir; Valine | 1997 |
A randomized, double-blind trial of valaciclovir prophylaxis for cytomegalovirus disease in patients with advanced human immunodeficiency virus infection. AIDS Clinical Trials Group Protocol 204/Glaxo Wellcome 123-014 International CMV Prophylaxis Study G
Topics: Acyclovir; Administration, Oral; Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; CD4 Lymphocyte Count; Cytomegalovirus Infections; Double-Blind Method; Female; Humans; Male; Valacyclovir; Valine | 1998 |
The effect of valaciclovir on cytomegalovirus viremia and viruria detected by polymerase chain reaction in patients with advanced human immunodeficiency virus disease. AIDS Clinical Trials Group Protocol 204/Glaxo Wellcome 123-014 International CMV Prophy
Topics: Acyclovir; Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; CD4 Lymphocyte Count; Cytomegalovirus; Cytomegalovirus Infections; DNA, Viral; Double-Blind Method; Female; Humans; Male; Multivariate Analysis; Polymerase Chain Reaction; Prognosis; Valacyclovir; Valine; Viremia | 1998 |
Valacyclovir for the prevention of cytomegalovirus disease after renal transplantation. International Valacyclovir Cytomegalovirus Prophylaxis Transplantation Study Group.
Topics: Acyclovir; Adult; Antiviral Agents; Cadaver; Cytomegalovirus; Cytomegalovirus Infections; Double-Blind Method; Female; Graft Rejection; Health Resources; Humans; Incidence; Kidney Transplantation; Male; Middle Aged; Postoperative Complications; Prodrugs; Serologic Tests; Valacyclovir; Valine | 1999 |
Quantitative effects of valacyclovir on the replication of cytomegalovirus (CMV) in persons with advanced human immunodeficiency virus disease: baseline CMV load dictates time to disease and survival. The AIDS Clinical Trials Group 204/Glaxo Wellcome 123-
Topics: Acyclovir; AIDS-Related Opportunistic Infections; Analysis of Variance; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; Disease-Free Survival; HIV Infections; Humans; Multivariate Analysis; Polymerase Chain Reaction; Prodrugs; Risk Factors; Survival Rate; Time Factors; Valacyclovir; Valine; Virus Replication | 1999 |
Valaciclovir prophylaxis of cytomegalovirus infection and disease in renal transplantation: an economic evaluation.
Topics: Acyclovir; Adolescent; Adult; Aged; Cost-Benefit Analysis; Cytomegalovirus Infections; Female; Humans; Kidney Transplantation; Male; Middle Aged; Valacyclovir; Valine | 2000 |
Valacyclovir study stopped -- worse survival.
Topics: Acyclovir; AIDS-Related Opportunistic Infections; CD4 Lymphocyte Count; Cytomegalovirus Infections; Dose-Response Relationship, Drug; Ethics, Medical; Humans; Placebos; Survival Analysis; Valacyclovir; Valine | 1995 |
Opportunistic infection highlights from the 35th ICAAC.
Topics: Acyclovir; AIDS-Related Opportunistic Infections; Antiviral Agents; Bacterial Vaccines; CD4 Lymphocyte Count; Cidofovir; Clinical Trials as Topic; Cytomegalovirus Infections; Cytosine; Drug Resistance, Microbial; Ganciclovir; HIV; Humans; Influenza Vaccines; Mycobacterium avium-intracellulare Infection; Organophosphonates; Organophosphorus Compounds; Pneumonia; Pneumonia, Pneumocystis; Randomized Controlled Trials as Topic; United States; Valacyclovir; Valine; Viremia | 1995 |
Ganciclovir studies leave clinicians confused.
Topics: Acyclovir; Administration, Oral; AIDS-Related Opportunistic Infections; Antiviral Agents; CD4 Lymphocyte Count; Cytomegalovirus Infections; Cytomegalovirus Retinitis; Ganciclovir; Humans; Placebos; Randomized Controlled Trials as Topic; Treatment Outcome; Valacyclovir; Valine | 1995 |
Valacyclovir prevention of cytomegalovirus reactivation after heart transplantation: a randomized trial.
Topics: Acyclovir; Adult; Antiviral Agents; Cytomegalovirus Infections; Dose-Response Relationship, Drug; Double-Blind Method; Endpoint Determination; Female; Graft Rejection; Heart Transplantation; Humans; Incidence; Male; Middle Aged; Severity of Illness Index; Time Factors; Treatment Outcome; United Kingdom; Valacyclovir; Valine | 2002 |
Randomized study of valacyclovir as prophylaxis against cytomegalovirus reactivation in recipients of allogeneic bone marrow transplants.
Topics: Acyclovir; Adolescent; Adult; Antiviral Agents; Bone Marrow Transplantation; Cytomegalovirus; Cytomegalovirus Infections; Double-Blind Method; Female; Humans; Male; Middle Aged; Prodrugs; Survival Analysis; Therapeutic Equivalency; Transplantation, Homologous; Valacyclovir; Valine; Virus Activation | 2002 |
Cytomegalovirus (CMV) polymerase chain reaction profiles in individuals with advanced human immunodeficiency virus infection: relationship to CMV disease.
Topics: Acyclovir; Adult; AIDS-Related Opportunistic Infections; Case-Control Studies; Cytomegalovirus; Cytomegalovirus Infections; HIV Infections; Humans; Male; Multivariate Analysis; Polymerase Chain Reaction; Predictive Value of Tests; Risk Factors; Valacyclovir; Valine | 2002 |
51 other study(ies) available for valine and Cytomegalovirus Infections
| Article | Year |
|---|---|
Cytomegalovirus prophylaxis in pediatric kidney transplantation: the Dutch experience.
Topics: Acyclovir; Adolescent; Antiviral Agents; Child; Child, Preschool; Cytomegalovirus; Cytomegalovirus Infections; Disease-Free Survival; Ganciclovir; Humans; Immunoglobulins; Immunosuppressive Agents; Infant; Kidney Transplantation; Netherlands; Polymerase Chain Reaction; Receptors, Interleukin-2; Renal Insufficiency; Retrospective Studies; Risk; Valacyclovir; Valganciclovir; Valine | 2013 |
Prophylaxis of human cytomegalovirus infection in renal transplant patients with valacyclovir and ganciclovir.
Topics: Acyclovir; Adult; Allografts; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; Female; Ganciclovir; Humans; Kidney Transplantation; Male; Middle Aged; Postoperative Complications; Valacyclovir; Valine | 2013 |
[Cytomegalovirus mononucleosis complicated with peripheral facial palsy].
Topics: Acyclovir; Adult; Antibodies, Viral; Antiviral Agents; Biomarkers; Cytomegalovirus; Cytomegalovirus Infections; Facial Paralysis; Female; Humans; Immunoglobulin M; Infectious Mononucleosis; Phosphoproteins; Prednisolone; Treatment Outcome; Valacyclovir; Valine; Viral Matrix Proteins | 2014 |
Fever and acute cytomegalovirus hepatitis in Crohn's disease.
Topics: Acyclovir; Adult; Antiviral Agents; Crohn Disease; Cytomegalovirus Infections; Fever; Humans; Ilium; Male; Valacyclovir; Valine | 2014 |
VZV encephalitis following successful treatment of CMV infection in a patient with kidney transplant.
Topics: Acyclovir; Aged; Antiviral Agents; Cytomegalovirus Infections; Diagnosis, Differential; Encephalitis, Varicella Zoster; Female; Herpesvirus 3, Human; Humans; Kidney Transplantation; Magnetic Resonance Imaging; Valacyclovir; Valine | 2014 |
Valganciclovir versus valacyclovir prophylaxis for prevention of cytomegalovirus: an economic perspective.
Topics: Acyclovir; Adult; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; Female; Follow-Up Studies; Ganciclovir; Humans; Kidney Transplantation; Male; Middle Aged; Postoperative Complications; Valacyclovir; Valganciclovir; Valine | 2015 |
Low-Dose Valacyclovir for Cytomegalovirus Infection Prophylaxis After a Heart Transplant.
Topics: Acyclovir; Adolescent; Adult; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; Drug Administration Schedule; Drug Therapy, Combination; Female; Heart Transplantation; Humans; Immunocompromised Host; Immunosuppressive Agents; Male; Middle Aged; Opportunistic Infections; Pneumonia, Viral; Risk Factors; Time Factors; Treatment Outcome; Valacyclovir; Valine; Virus Activation; Young Adult | 2016 |
Efficacy of oral valacyclovir in cytomegalovirus-infected fetuses.
Topics: Acyclovir; Administration, Oral; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; Fetus; Humans; Valacyclovir; Valine | 2017 |
Valganciclovir versus valaciclovir for prevention of alemtuzumab-induced cytomegalovirus reactivation: what are the implications for routine clinical practice?
Topics: Acyclovir; Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Antineoplastic Agents; Antiviral Agents; Cytomegalovirus Infections; Ganciclovir; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Valacyclovir; Valganciclovir; Valine | 2008 |
Six months anti-viral prophylaxis significantly decreased cytomegalovirus disease compared with no anti-viral prophylaxis following renal transplantation.
Topics: Acyclovir; Antiviral Agents; Cytomegalovirus Infections; Female; Follow-Up Studies; Ganciclovir; Graft Survival; Humans; Incidence; Injections, Intravenous; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; Prodrugs; Retrospective Studies; Survival Rate; Time Factors; Treatment Outcome; Valacyclovir; Valganciclovir; Valine | 2010 |
Neutropenia related to valacyclovir and valganciclovir in 2 renal transplant patients and treatment with granulocyte colony stimulating factor: a case report.
Topics: Acyclovir; Adolescent; Adult; Antiviral Agents; Cytomegalovirus Infections; Filgrastim; Ganciclovir; Granulocyte Colony-Stimulating Factor; Humans; Kidney Transplantation; Male; Neutropenia; Recombinant Proteins; Treatment Outcome; Valacyclovir; Valganciclovir; Valine | 2010 |
Atypical presentation of cytomegalovirus endotheliitis: a case report.
Topics: Acyclovir; Aged; Antiviral Agents; Corneal Edema; Cytomegalovirus; Cytomegalovirus Infections; DNA, Viral; Endothelium, Corneal; Ganciclovir; Humans; Intraocular Pressure; Keratitis, Herpetic; Male; Prednisolone; Valacyclovir; Valganciclovir; Valine; Visual Acuity | 2011 |
Low-dose valaciclovir and cytomegalovirus immunoglobulin to prevent cytomegalovirus disease in high-risk renal transplant recipients.
Topics: Acyclovir; Adolescent; Adult; Aged; Cytomegalovirus; Cytomegalovirus Infections; Humans; Immunoglobulins; Incidence; Kidney Transplantation; Male; Middle Aged; Retrospective Studies; Tissue Donors; Valacyclovir; Valine; Young Adult | 2011 |
Valganciclovir prophylaxis against cytomegalovirus impairs lymphocyte proliferation and activation in renal transplant recipients.
Topics: Acyclovir; Adult; Antiviral Agents; Cell Proliferation; Cells, Cultured; Concanavalin A; Cytomegalovirus; Cytomegalovirus Infections; Female; Ganciclovir; Graft Rejection; Graft Survival; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Kidney Transplantation; Lymphocyte Activation; Lymphocyte Count; Male; Middle Aged; Phytohemagglutinins; T-Lymphocyte Subsets; Valacyclovir; Valganciclovir; Valine | 2011 |
Cytomegalovirus colitis.
Topics: Acyclovir; Antiviral Agents; Azathioprine; Colitis; Cytomegalovirus Infections; Female; Ganciclovir; Humans; Immunosuppressive Agents; Valacyclovir; Valine; Young Adult | 2012 |
The antiviral drug valacyclovir successfully suppresses salivary gland hypertrophy virus (SGHV) in laboratory colonies of Glossina pallidipes.
Topics: Acyclovir; Animals; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; Tsetse Flies; Valacyclovir; Valine | 2012 |
Randomized trial of pre-emptive or prophylactic valganciclovir therapy for prevention of cytomegalovirus infection in renal transplantation.
Topics: Acyclovir; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; Female; Ganciclovir; Humans; Kidney Transplantation; Male; Valacyclovir; Valganciclovir; Valine | 2012 |
Concurrent cytomegalovirus and herpes simplex virus infection in pemphigus vulgaris treated with rituximab and prednisolone.
Topics: Acyclovir; Aged; Antibodies, Monoclonal, Murine-Derived; Antiviral Agents; Biopsy; Cytomegalovirus Infections; Drug Therapy, Combination; Glucocorticoids; Herpes Simplex; Humans; Immunocompromised Host; Immunosuppressive Agents; Male; Pemphigus; Prednisolone; Rituximab; Skin; Treatment Outcome; Valacyclovir; Valine | 2013 |
Cytomegalovirus prophylaxis in solid organ transplantation.
Topics: Acyclovir; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; Ganciclovir; Graft Rejection; Humans; Immunity, Cellular; Immunosuppressive Agents; Risk Factors; Tissue Transplantation; Valacyclovir; Valganciclovir; Valine | 2012 |
Antiviral therapy can reverse the development of immune senescence in elderly mice with latent cytomegalovirus infection.
Topics: Acyclovir; Animals; Antiviral Agents; CD8-Positive T-Lymphocytes; Cytomegalovirus Infections; Female; Immunologic Memory; Mice; Mice, Inbred C57BL; Muromegalovirus; Valacyclovir; Valine; Virus Activation; Virus Latency | 2013 |
Clinical outcome with low-dose valacyclovir in high-risk renal transplant recipients: a 10-year experience.
Topics: Acyclovir; Adult; Antibiotic Prophylaxis; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; Female; Follow-Up Studies; Glomerular Filtration Rate; Graft Rejection; Graft Survival; Humans; Kidney Transplantation; Male; Middle Aged; Postoperative Complications; Prognosis; Renal Insufficiency, Chronic; Retrospective Studies; Survival Rate; Time Factors; Valacyclovir; Valine | 2013 |
Prevention of cytomegalovirus disease in hematopoietic stem cell transplantation.
Topics: Acyclovir; Antiviral Agents; Chemoprevention; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; Ganciclovir; Hematopoietic Stem Cell Transplantation; Humans; Organophosphonates; Organophosphorus Compounds; Postoperative Complications; Risk Factors; Transplantation, Autologous; Transplantation, Homologous; Valacyclovir; Valganciclovir; Valine | 2002 |
Lowering immunosuppression is safe and effective to treat altered pattern of CMV infection in renal transplant recipients on valaciclovir prophylaxis.
Topics: Acyclovir; Antigens, Viral; Antiviral Agents; Cytomegalovirus Infections; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Kidney Transplantation; Prodrugs; Valacyclovir; Valine | 2002 |
Valacyclovir for the prevention of cytomegalovirus infection after kidney transplantation is associated with macrocytosis.
Topics: Acyclovir; Antiviral Agents; Cytomegalovirus Infections; Erythrocyte Indices; Erythrocytes, Abnormal; Female; Humans; Kidney Transplantation; Male; Middle Aged; Valacyclovir; Valine | 2003 |
Comparative study of prophylactic oral ganciclovir and valacyclovir in high-risk kidney transplant recipients.
Topics: Acyclovir; Administration, Oral; Adult; Cytomegalovirus Infections; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Ganciclovir; Graft Rejection; Graft Survival; Humans; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; Opportunistic Infections; Preoperative Care; Probability; Retrospective Studies; Risk Assessment; Treatment Outcome; Valacyclovir; Valine | 2003 |
A neutropenia suggesting an interaction between valacyclovir and mycophenolate mofetil.
Topics: Acyclovir; Antiviral Agents; Cytomegalovirus Infections; Drug Interactions; Female; Humans; Immunosuppressive Agents; Kidney Transplantation; Middle Aged; Mycophenolic Acid; Neutropenia; Valacyclovir; Valine | 2003 |
Low-dose valaciclovir prophylaxis against cytomegalovirus disease in renal transplant recipients.
Topics: Acyclovir; Adult; Antiviral Agents; Cytomegalovirus Infections; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Kidney Transplantation; Living Donors; Male; Postoperative Complications; Prodrugs; Reoperation; Retrospective Studies; Tissue Donors; Valacyclovir; Valine | 2003 |
Efficacy and safety of lowering immunosuppression to treat CMV infection in renal transplant recipients on valaciclovir prophylaxis: a pilot study.
Topics: Acyclovir; Adult; Antibodies, Viral; Antiviral Agents; Cytomegalovirus Infections; Female; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Pilot Projects; Valacyclovir; Valine | 2003 |
A decision-analytic economic evaluation of valaciclovir prophylaxis for the prevention of cytomegalovirus infection and disease in renal transplantation.
Topics: Acyclovir; Antiviral Agents; Chemoprevention; Cost-Benefit Analysis; Cytomegalovirus Infections; Graft Survival; Humans; Kidney Transplantation; Markov Chains; Models, Biological; Models, Economic; Quality of Life; Survival Analysis; Treatment Outcome; Valacyclovir; Valine | 2004 |
Detection of ganciclovir resistance after valacyclovir-prophylaxis in renal transplant recipients with active cytomegalovirus infection.
Topics: Acyclovir; Amino Acid Substitution; Antiviral Agents; Chemoprevention; Cytomegalovirus; Cytomegalovirus Infections; Drug Resistance, Viral; Female; Ganciclovir; Humans; Kidney Transplantation; Middle Aged; Phosphoproteins; Phosphotransferases (Alcohol Group Acceptor); Pilot Projects; Retrospective Studies; Valacyclovir; Valine; Viral Matrix Proteins | 2004 |
The cost-effectiveness of prophylaxis with valaciclovir in the management of cytomegalovirus after renal transplantation.
Topics: Acyclovir; Antiviral Agents; Cost-Benefit Analysis; Cytomegalovirus; Cytomegalovirus Infections; Humans; Immunocompromised Host; Kidney Transplantation; Valacyclovir; Valine | 2005 |
Drugs for non-HIV viral infections.
Topics: 2-Aminopurine; Acyclovir; Antiviral Agents; Cytomegalovirus Infections; Drug Resistance, Viral; Famciclovir; Guanine; Hepatitis B; Hepatitis C; Herpes Simplex; Herpes Zoster; Humans; Influenza, Human; Valacyclovir; Valine; Virus Diseases | 2005 |
Early selection of a new UL97 mutant with a severe defect of ganciclovir phosphorylation after valaciclovir prophylaxis and short-term ganciclovir therapy in a renal transplant recipient.
Topics: Acyclovir; Adolescent; Antiviral Agents; Chemoprevention; Codon; Cytomegalovirus; Cytomegalovirus Infections; Drug Resistance, Viral; Ganciclovir; Humans; Kidney Transplantation; Molecular Sequence Data; Phosphorylation; Phosphotransferases (Alcohol Group Acceptor); Sequence Deletion; Valacyclovir; Valine | 2005 |
Cytomegalovirus DNAemia and disease: incidence, natural history and management in settings other than allogeneic stem cell transplantation.
Topics: Acyclovir; Adult; Aged; Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murine-Derived; Antibodies, Neoplasm; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Cohort Studies; Cyclophosphamide; Cytomegalovirus; Cytomegalovirus Infections; Dexamethasone; Diphtheria Toxin; DNA, Viral; Doxorubicin; Female; Fever; Follow-Up Studies; Ganciclovir; Hematologic Neoplasms; Humans; Interleukin-2; Male; Middle Aged; Peripheral Blood Stem Cell Transplantation; Polymerase Chain Reaction; Recombinant Fusion Proteins; Retrospective Studies; Rituximab; Transplantation, Autologous; Valacyclovir; Valine; Vidarabine; Vincristine; Viremia; Virus Activation | 2005 |
Adverse neuropsychiatric effects of cytomegalovirus prophylaxis with valaciclovir in renal transplant recipients.
Topics: Acyclovir; Adult; Age Distribution; Analysis of Variance; Behavioral Symptoms; Cohort Studies; Cytomegalovirus Infections; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; France; Graft Rejection; Humans; Incidence; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; Neuropsychological Tests; Probability; Prognosis; Retrospective Studies; Risk Assessment; Sex Distribution; Valacyclovir; Valine | 2006 |
Anti-cytomegalovirus prophylaxis in solid-organ transplant recipients.
Topics: Acyclovir; Antiviral Agents; Cytomegalovirus Infections; Ganciclovir; Humans; Organ Transplantation; Valacyclovir; Valganciclovir; Valine | 2006 |
Maternal administration of valaciclovir in symptomatic intrauterine cytomegalovirus infection.
Topics: Acyclovir; Administration, Oral; Antiviral Agents; Cytomegalovirus Infections; DNA, Viral; Female; Fetal Blood; Fetal Diseases; Humans; Pilot Projects; Platelet Count; Pregnancy; Pregnancy Complications, Infectious; Self Administration; Valacyclovir; Valine; Viral Load | 2007 |
Cytomegalovirus as an etiologic factor in corneal endotheliitis.
Topics: Acyclovir; Administration, Topical; Aged; Aged, 80 and over; Antiviral Agents; Aqueous Humor; Cell Count; Cytomegalovirus; Cytomegalovirus Infections; DNA, Viral; Endothelium, Corneal; Eye Infections, Viral; Female; Ganciclovir; Humans; Keratitis; Male; Middle Aged; Polymerase Chain Reaction; Retrospective Studies; Valacyclovir; Valine | 2008 |
Essential and nonessential amino acids in appropriate and small for gestational age fetuses with congenital cytomegalovirus infection.
Topics: Cordocentesis; Cytomegalovirus Infections; Female; Fetal Blood; Fetal Diseases; Fetal Growth Retardation; Gestational Age; Glycine; Humans; Pregnancy; Valine | 1997 |
Successful use of oral valacyclovir in post-transplant cytomegalovirus infection in renal allograft recipients.
Topics: Acyclovir; Administration, Oral; Adult; Antiviral Agents; Cytomegalovirus Infections; Female; Humans; Kidney Transplantation; Middle Aged; Postoperative Complications; Valacyclovir; Valine | 1998 |
The renal safety of high doses of valacyclovir for prevention of cytomegalovirus infection after renal transplantation.
Topics: Acyclovir; Antiviral Agents; Cytomegalovirus Infections; Dose-Response Relationship, Drug; Humans; Kidney; Kidney Transplantation; Postoperative Complications; Safety; Valacyclovir; Valine | 2000 |
Ganciclovir-resistant cytomegalovirus.
Topics: Acyclovir; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; Drug Resistance, Microbial; Ganciclovir; Humans; Organ Transplantation; Postoperative Complications; Valacyclovir; Valine | 2000 |
Cost-effectiveness model of cytomegalovirus management strategies in renal transplantation. Comparing valaciclovir prophylaxis with current practice.
Topics: Acyclovir; Administration, Oral; Algorithms; Antiviral Agents; Cost-Benefit Analysis; Cytomegalovirus Infections; Decision Trees; Drug Costs; Ganciclovir; Humans; Injections, Intravenous; Kidney Transplantation; Postoperative Complications; Premedication; Valacyclovir; Valine; Virus Shedding | 2000 |
Preventing opportunistic infections.
Topics: Acyclovir; AIDS-Related Opportunistic Infections; Clarithromycin; Clindamycin; Clinical Trials as Topic; Clotrimazole; Cytomegalovirus Infections; Dapsone; Fluconazole; Ganciclovir; Humans; Itraconazole; Leucovorin; Mycobacterium avium-intracellulare Infection; Mycoses; Pentamidine; Pneumonia, Pneumocystis; Pyrimethamine; Rifabutin; Toxoplasmosis; Trimethoprim, Sulfamethoxazole Drug Combination; Valacyclovir; Valine | 1995 |
CTG studies yield results. AIDS Clinical Trials Group.
Topics: Acyclovir; Child; Clinical Trials as Topic; Cytomegalovirus Infections; Didanosine; Drug Therapy, Combination; Fluconazole; HIV Infections; Humans; Mycoses; Pneumonia, Pneumocystis; Valacyclovir; Valine; Zidovudine | 1995 |
Spectrum and treatment of cytomegalovirus disease in persons with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Antiviral Agents; Central Nervous System Diseases; Cytomegalovirus Infections; Cytomegalovirus Retinitis; Digestive System Diseases; Foscarnet; Ganciclovir; Humans; Valacyclovir; Valine | 1996 |
The status of CMV viral load testing.
Topics: Acyclovir; Administration, Oral; Antiviral Agents; CD4 Lymphocyte Count; Cytomegalovirus; Cytomegalovirus Infections; Ganciclovir; HIV Infections; Humans; Polymerase Chain Reaction; Prospective Studies; Valacyclovir; Valine; Viral Load; Viremia | 1996 |
High-dose valaciclovir linked to problems.
Topics: Acyclovir; Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; CD4 Lymphocyte Count; Cytomegalovirus Infections; Dose-Response Relationship, Drug; Female; Humans; Male; Valacyclovir; Valine | 1998 |
Valacyclovir for the prevention of cytomegalovirus infection after allogeneic stem cell transplantation: a single institution retrospective cohort analysis.
Topics: Acyclovir; Adult; Antiviral Agents; Cohort Studies; Consumer Product Safety; Cytomegalovirus Infections; Female; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Phosphoproteins; Retrospective Studies; Therapeutic Equivalency; Transplantation, Homologous; Valacyclovir; Valine; Viral Matrix Proteins; Virus Activation | 2001 |
CMV disease in CMV-mismatched renal transplant recipients with prophylactic low dose valaciclovir.
Topics: Acyclovir; Adult; Aged; Antiviral Agents; Cytomegalovirus Infections; Female; Graft Survival; Humans; Incidence; Kidney Transplantation; Male; Middle Aged; Postoperative Complications; Retrospective Studies; Valacyclovir; Valine | 2001 |
Prophylaxis of cytomegalovirus infection in renal transplantation.
Topics: Acyclovir; Antiviral Agents; Cytomegalovirus Infections; Female; Humans; Kidney Transplantation; Male; Valacyclovir; Valine | 2001 |